An Open-Label Drug-Drug Interaction Study in Healthy Subjects to Explore the Effects of Multiple Doses of JNJ-28431754 on the Pharmacokinetics and Safety of Single Doses of Glyburide
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Canagliflozin (Primary) ; Glibenclamide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 03 Jan 2013 New trial record